As a preclinical CRO specializing in oncology, Alfa Cytology provides monoclonal stable cell line construction services to generate highly homogeneous and well-characterized cell lines that meet the stringent requirements of precision research and regulatory submissions. Utilizing limiting dilution or single-cell sorting technologies, we isolate individual cells and expand them into clonal populations with consistent expression profiles, delivering reliable and reproducible results for your oncology research.
Monoclonal stable cell lines are cell populations derived from a single progenitor cell and expanded through culture, with all cells sharing identical genetic backgrounds and expression characteristics. Unlike polyclonal pools consisting of mixed cell populations, monoclonal cell lines provide consistent and predictable performance across experiments and passages. The development of monoclonal cell lines involves a rigorous workflow encompassing single-cell isolation, clonal expansion, and multi-tiered screening. Through limiting dilution or FACS-based single-cell sorting, individual cells are isolated from mixed populations, stepwise expanded, and subjected to multiple rounds of screening to identify clones with optimal performance, ultimately establishing highly homogeneous and well-characterized cell lines. Monoclonal cell lines are the preferred tools for precision research and regulatory submissions. Their high homogeneity and stable expression levels ensure experimental reproducibility and reliability, which are fundamental requirements for cell models in IND-enabling studies. Moreover, monoclonal cell lines represent the gold standard for cell line development in biopharmaceutical manufacturing. Consequently, monoclonal stable cell lines have become indispensable core tools in precision oncology research and commercial development.
Fig. 1 Workflow of monoclonal cells selection after lentivirus infection. (Ye M, et al.; 2021)
Alfa Cytology provides professional monoclonal stable cell line construction services dedicated to transforming your research needs into highly homogeneous, well-characterized, and regulatory-compliant cellular models. From single-cell isolation, clonal screening and expansion, to comprehensive quality validation and cell banking, we offer customized solutions covering the entire workflow.
Leveraging our extensive engineering experience across diverse tumor cell lines and a rigorous quality system, we ensure that every monoclonal cell line we delivers possesses genetic homogeneity, expression stability, and complete documentation support, providing reliable cellular tools for your precision research, biopharmaceutical manufacturing, and IND-enabling studies.
| Service Step | Service Details | Turnaround Time |
|---|---|---|
| Vector Construction and Stable Transfection | Design expression vectors with selection markers, transfect into host cells, enrich stable pools via antibiotic selection, and isolate single cells into 96-well plates by limiting dilution or FACS (monoclonality ≥95%).
|
3–4 weeks |
| Clone Screening and Expansion | Culture for 2–3 weeks, remove slow-growing clones, screen high-expression clones by qPCR/Western blot/flow cytometry, and expand from 96-well to 6-well plates, narrowing ~200 clones to 20–30.
|
6–8 weeks |
| Shake Flask Evaluation and Final Clone Selection |
|
3–4 weeks |
| Stability Testing | Passage final clones for ≥20 generations with sampling at P5/P10/P15/P20 to assess expression, viability, and doubling time, ensuring consistency (CV ≤ 30%). | 8–12 weeks |
| Cell Banking and Quality Release |
|
3–5 weeks |
Our monoclonal stable cell line construction services support a broad spectrum of cancer types, providing highly homogeneous and well-characterized cell lines for precision research, biopharmaceutical production, and IND-enabling studies, including but not limited to:
Ready to advance your oncology research with our monoclonal stable cell line construction services? Whether you require stable cell lines for biopharmaceutical manufacturing or highly homogeneous cellular models for long-term functional studies, Alfa Cytology is fully prepared to assist you. Contact our scientific team today to discuss your specific monoclonal cell line needs and discover how our expertise can accelerate your oncology research programs.
Reference
For research use only.
Alfa Cytology, a preclinical research solution provider, provides its clients with one-stop solutions to accelerate cancer therapeutics discovery and development.
Copyright © 2026 Alfa Cytology. All rights reserved.
